
EMBO Mol. Medicine
@embomolmed
#OpenAccess journal dedicated to high quality research at the interface between clinical & basic science. @EMBOPress, tweets from journal editors
ID: 2233090550
http://www.embomolmed.org 06-12-2013 14:43:52
4,4K Tweet
9,9K Followers
186 Following

"Improving the odds of survival: transgenerational effects of infections" 👉Read the review by V. Spanou, T. Andriopoulou, E. Giamarellos-Bourboulis & M. Neteai at University of Athens & Radboudumc 🗞️doi.org/10.1038/s44321…


Review by M. Moll & D. Baumjohann Uniklinik Bonn ➡️Boosting human immunology: harnessing the potential of immune organoids. 🗞️doi.org/10.1038/s44321…




Exploiting #MetabolicVulnerability in #glioblastoma using a brain-penetrant drug with a safe profile By Audrey Burban, Andreas Bikfalvi, @Thomas_Daubon, Ahmad Sharanek & colleagues Inserm & Bordeaux University ➡️doi.org/10.1038/s44321…


Online today ➡️#MicrobialMetabolites tune #amygdala neuronal hyperexcitability and #anxiety -linked behaviors. By W. Yu, Y. Xiao, S. Pettersson, H.S. Je & colleagues Duke-NUS Medical School 🗞️doi.org/10.1038/s44321…


Are you attending the #EMBOmetabolicDiseases meeting in beautiful Torremolinos? So is our editor Deniz Senyilmaz Tiebe! Talk to her if you are looking for a home for your paper or about scientific publishing. EMBO Events EMBO Press






🧬 Dr. Abdel-Majid Khatib's team at BRIC-Bordeaux explored the therapeutic potential of targeting proapelin cleavage sites in metastatic #CRC by introducing apelin-dm, a variant resulting from alteration in proapelin cleavage sites. EMBO Mol. Medicine | bit.ly/4k5Aff1


Excited to share this new collaborative EMBO Mol. Medicine work from my lab ChildrensAL & Jim Dowling labs. Work highlights efforts to generate a new animal model for X-linked myopathy with excessive autophagy (XMEA) and perform corrective drug screening. 1/n tinyurl.com/ym7svnwm


